Healthcare providers are sitting on an untapped opportunity hidden within routine chest CT scans. With the introduction of Medicare code G0680, effective April 1, 2026, AI-powered detection and quantification of coronary artery calcium (CAC) and aortic valve calcification (AVC) can now be reimbursed—creating a new pathway to generate revenue from imaging studies already being performed every day.
ClearRead™ CT is purpose-built to help providers capture this opportunity. As an AI-powered solution, it automatically detects and quantifies coronary artery calcium from routine chest CT scans, aligning directly with G0680 requirements. The platform works on existing non-gated, non-contrast scans and delivers standardized scoring with structured, billable reports—making it easy to operationalize CAC analysis without adding burden to radiology teams.
ClearRead CT is a cardiothoracic AI suite for pulmonary nodule detection and CAC scoring. Proven to reduce total reading time by 36%1, a series of advanced AI algorithms are deployed that target complex and time-consuming conditions like lung cancer and cardiovascular disease. The unique and patented vessel suppression solution provides an unimpaired view of the lung for improved visualization of nodules. Pulmonary nodule findings are segmented and quantified, and prior exams are used for comparison. Then, an Agatston score is calculated for CAC on every ungated, non-contrast CT. ClearRead CT delivers proven accuracy, seamless workflow, and time-saving insights that ease cognitive burden and improve patient outcomes.
G0680 reimbursement is specific to the Hospital Outpatient Prospective Payment System (OPPS), meaning eligibility applies to outpatient hospital settings where many chest CTs are already performed. Reimbursement is carrier-priced, with rates determined by regional Medicare Administrative Contractors (MACs), so payment levels may vary by geography. Additionally, payment depends on the OPPS Status Indicator (SI): in some cases, CAC analysis may be reimbursed separately, while in others it may be packaged into the primary CT scan payment. Understanding these nuances is critical to accurately forecasting financial impact and maximizing reimbursement potential. Download the CAC Reimbursement Infographic to learn more about the reimbursement code and how ClearRead CT aligns completely with all requirements.
The result is a powerful combination of improved patient care and new revenue potential—powered by ClearRead CT and the scans you already have. Ready to see the financial impact for your organization? Visit the ROI calculator to estimate your CAC reimbursement opportunity and take the next step toward AI-enabled imaging value or schedule a call for a customized proforma for your organization by filling out the short form.
1Chorath, K., Tharp, K., Watt, C., Bresnahan, B. W., Medverd, J. R., Cross, N. M., & Chalian, H. (2024, December 4). Unveiling the impact of Riverain’s vessel suppression: Breakthrough or bust? [Scientific poster presentation]. RSNA 2024 Annual Meeting, Chicago, IL.
